Australia to Ban Non-Prescription Vapes in Major Reform

May.02.2023
Australia to Ban Non-Prescription Vapes in Major Reform
Australia bans non-prescription e-cigarettes, sets quality standards, and invests $234 million in smoking reforms.

On May 1st, according to a report from The Guardian, Australian Health Minister Mark Butler announced that the government will ban the importation of non-prescription electronic cigarette products. The government will also establish minimum quality standards which will include restricting e-cigarette flavors, packaging colors, and other ingredients. Similar to pharmaceuticals, packaging will indicate reduced nicotine concentration and capacity. Additionally, single-use e-cigarettes will be explicitly prohibited.


Determined to eliminate the "public health threat".


A previous investigation was conducted by Australia's Therapeutic Goods Administration (TGA) on the regulation reform of e-cigarettes within the country. The majority of materials submitted by relevant health organizations supported increasing border control.


They believe that the focus of border control is on non-nicotine electronic cigarette products.


Electronic cigarette manufacturers have falsely labeled products containing nicotine as "nicotine-free" to circumvent import restrictions.


This makes it easy for children to buy electronic cigarettes and often unknowingly inhale nicotine, leading to addiction.


The Minister of Health, Mr. Butler, said in a television program that the tobacco industry is attempting to create a "new generation of nicotine addicts" through the production of e-cigarettes. He stated that he is determined to eliminate this public health threat.


The Australian government will collaborate with states and territories to put an end to the sale of electronic cigarettes in convenience stores and other retail shops. They will also establish stricter guidelines for the sale of e-cigarette products in pharmacies, in order to ensure the contents are safe for consumers.


The largest loophole in Australian history


Butler is expected to outline these reforms in a speech at the National Press Club. According to a leaked copy of the speech, Butler believes that e-cigarettes have become "the biggest loophole in Australian history" and has announced that the government will invest AUD 234 million (approximately RMB 1.07 billion) into reforms relating to tobacco and e-cigarettes.


The speech by Butler stated that electronic cigarettes are being marketed as a therapeutic product to governments and communities around the world to aid long-term smokers in quitting.


It was never intended to be sold as an entertainment product, especially not one suitable for our children. But that is what it has become: the biggest loophole in Australian history.


A sum of 63 million Australian dollars (approximately 289 million yuan) will be utilized for public health advocacy campaigns aimed at preventing smoking and the use of e-cigarettes while also promoting smoking cessation.


Additionally, 30 million Australian dollars (approximately 138 million Chinese yuan) will be invested in a support program to help Australians quit smoking, and there will be an increased effort to educate and train healthcare professionals on smoking cessation and nicotine addiction.


According to Terry Slevin, CEO of the Australian Public Health Association, the upcoming reforms by the Australian government describe electronic cigarettes as a "public health disaster". He stated that the reforms will make Australia a world leader in controlling tobacco and e-cigarettes.


Laura Hunter, joint CEO of the Australian Smoking and Health Council, says it is encouraging to see the government take decisive action against a harmful industry.


She stated that the government's plan is largely normalizing the culture of e-cigarettes.


Further reading:


Australia may implement a complete ban on imported electronic cigarettes.


An Australian state plans to broaden the scope of smoke-free public spaces and double fines for selling e-cigarettes to minors.


Australia to introduce plain packaging and flavor bans, and strengthen border control measures.


Reference list:


Australia is set to implement its most significant smoking reforms in a decade by banning the sale of non-prescription vapes.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12